---
document_datetime: 2025-11-23 08:01:56
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/trudexa.html
document_name: trudexa.html
version: success
processing_time: 0.1061982
conversion_datetime: 2025-12-27 21:37:58.055774
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Trudexa

[RSS](/en/individual-human-medicine.xml/66493)

##### Withdrawn

This medicine's authorisation has been withdrawn

adalimumab

Medicine

Human

Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 1 September 2003 the European Commission issued a marketing authorisation valid throughout the European Union for the medicinal product Trudexa, 40 mg solution for injection, intended for the treatment of rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. The marketing authorisation holder (MAH) responsible for Trudexa is Abbott Laboratories.

On 20 June 2007, the European Commission was notified by the MAH of its decision to voluntarily withdraw the marketing authorisation for Trudexa for commercial reasons. Trudexa was never placed onto the market in any member state of the European Economic Area. Therapeutic alternatives are available throughout the European Union, including an identical product, Humira, and other tumour necrosis factor (TNF) blockers. On 9 July 2007 the European Commission issued a decision to withdraw the marketing authorisation for Trudexa.

Pursuant to this decision the European Public Assessment Report for Trudexa is updated to reflect that the marketing authorisation is no longer valid.

Trudexa : EPAR - Summary for the public

English (EN) (250.38 KB - PDF)

**First published:** 15/02/2008

**Last updated:** 15/02/2008

[View](/en/documents/overview/trudexa-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-189)

български (BG) (427.75 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/bg/documents/overview/trudexa-epar-summary-public_bg.pdf)

español (ES) (254.83 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/es/documents/overview/trudexa-epar-summary-public_es.pdf)

čeština (CS) (403.29 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/cs/documents/overview/trudexa-epar-summary-public_cs.pdf)

dansk (DA) (254.67 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/da/documents/overview/trudexa-epar-summary-public_da.pdf)

Deutsch (DE) (256.5 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/de/documents/overview/trudexa-epar-summary-public_de.pdf)

eesti keel (ET) (252.67 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/et/documents/overview/trudexa-epar-summary-public_et.pdf)

ελληνικά (EL) (427.9 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/el/documents/overview/trudexa-epar-summary-public_el.pdf)

français (FR) (256.15 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/fr/documents/overview/trudexa-epar-summary-public_fr.pdf)

italiano (IT) (254.84 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/it/documents/overview/trudexa-epar-summary-public_it.pdf)

latviešu valoda (LV) (404.05 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/lv/documents/overview/trudexa-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (373.8 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/lt/documents/overview/trudexa-epar-summary-public_lt.pdf)

magyar (HU) (388.14 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/hu/documents/overview/trudexa-epar-summary-public_hu.pdf)

Malti (MT) (400.22 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/mt/documents/overview/trudexa-epar-summary-public_mt.pdf)

Nederlands (NL) (255.91 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/nl/documents/overview/trudexa-epar-summary-public_nl.pdf)

polski (PL) (409.13 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/pl/documents/overview/trudexa-epar-summary-public_pl.pdf)

português (PT) (255.89 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/pt/documents/overview/trudexa-epar-summary-public_pt.pdf)

română (RO) (366.36 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/ro/documents/overview/trudexa-epar-summary-public_ro.pdf)

slovenčina (SK) (391.06 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/sk/documents/overview/trudexa-epar-summary-public_sk.pdf)

slovenščina (SL) (384.48 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/sl/documents/overview/trudexa-epar-summary-public_sl.pdf)

Suomi (FI) (253.07 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/fi/documents/overview/trudexa-epar-summary-public_fi.pdf)

svenska (SV) (252.25 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/sv/documents/overview/trudexa-epar-summary-public_sv.pdf)

## Product information

Trudexa : EPAR - Product Information

English (EN) (1.25 MB - PDF)

**First published:** 15/02/2008

**Last updated:** 15/02/2008

[View](/en/documents/product-information/trudexa-epar-product-information_en.pdf)

[Other languages (21)](#file-language-dropdown-270)

български (BG) (2.4 MB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/bg/documents/product-information/trudexa-epar-product-information_bg.pdf)

español (ES) (1.4 MB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/es/documents/product-information/trudexa-epar-product-information_es.pdf)

čeština (CS) (1.6 MB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/cs/documents/product-information/trudexa-epar-product-information_cs.pdf)

dansk (DA) (1.31 MB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/da/documents/product-information/trudexa-epar-product-information_da.pdf)

Deutsch (DE) (1.44 MB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/de/documents/product-information/trudexa-epar-product-information_de.pdf)

eesti keel (ET) (1.32 MB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/et/documents/product-information/trudexa-epar-product-information_et.pdf)

ελληνικά (EL) (2.3 MB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/el/documents/product-information/trudexa-epar-product-information_el.pdf)

français (FR) (1.44 MB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/fr/documents/product-information/trudexa-epar-product-information_fr.pdf)

italiano (IT) (1.41 MB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/it/documents/product-information/trudexa-epar-product-information_it.pdf)

latviešu valoda (LV) (1.96 MB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/lv/documents/product-information/trudexa-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.76 MB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/lt/documents/product-information/trudexa-epar-product-information_lt.pdf)

magyar (HU) (1.61 MB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/hu/documents/product-information/trudexa-epar-product-information_hu.pdf)

Malti (MT) (1.81 MB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/mt/documents/product-information/trudexa-epar-product-information_mt.pdf)

Nederlands (NL) (1.32 MB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/nl/documents/product-information/trudexa-epar-product-information_nl.pdf)

polski (PL) (1.89 MB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/pl/documents/product-information/trudexa-epar-product-information_pl.pdf)

português (PT) (1.42 MB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/pt/documents/product-information/trudexa-epar-product-information_pt.pdf)

română (RO) (1.71 MB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/ro/documents/product-information/trudexa-epar-product-information_ro.pdf)

slovenčina (SK) (1.67 MB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/sk/documents/product-information/trudexa-epar-product-information_sk.pdf)

slovenščina (SL) (1.44 MB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/sl/documents/product-information/trudexa-epar-product-information_sl.pdf)

Suomi (FI) (1.37 MB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/fi/documents/product-information/trudexa-epar-product-information_fi.pdf)

svenska (SV) (1.28 MB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/sv/documents/product-information/trudexa-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** II/0037 29/06/2007

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Trudexa : EPAR - All Authorised presentations

English (EN) (229.04 KB - PDF)

**First published:** 15/02/2008

**Last updated:** 15/02/2008

[View](/en/documents/all-authorised-presentations/trudexa-epar-all-authorised-presentations_en.pdf)

[Other languages (18)](#file-language-dropdown-562)

español (ES) (229.96 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/es/documents/all-authorised-presentations/trudexa-epar-all-authorised-presentations_es.pdf)

čeština (CS) (327.26 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/cs/documents/all-authorised-presentations/trudexa-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (230 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/da/documents/all-authorised-presentations/trudexa-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (230.72 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/de/documents/all-authorised-presentations/trudexa-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (229.68 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/et/documents/all-authorised-presentations/trudexa-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (329.58 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/el/documents/all-authorised-presentations/trudexa-epar-all-authorised-presentations_el.pdf)

français (FR) (229.53 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/fr/documents/all-authorised-presentations/trudexa-epar-all-authorised-presentations_fr.pdf)

italiano (IT) (229.88 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/it/documents/all-authorised-presentations/trudexa-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (302.5 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/lv/documents/all-authorised-presentations/trudexa-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (302.19 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/lt/documents/all-authorised-presentations/trudexa-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (322.65 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/hu/documents/all-authorised-presentations/trudexa-epar-all-authorised-presentations_hu.pdf)

Nederlands (NL) (229.07 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/nl/documents/all-authorised-presentations/trudexa-epar-all-authorised-presentations_nl.pdf)

polski (PL) (327.46 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/pl/documents/all-authorised-presentations/trudexa-epar-all-authorised-presentations_pl.pdf)

português (PT) (229.36 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/pt/documents/all-authorised-presentations/trudexa-epar-all-authorised-presentations_pt.pdf)

slovenčina (SK) (324.05 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/sk/documents/all-authorised-presentations/trudexa-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (293.16 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/sl/documents/all-authorised-presentations/trudexa-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (228.85 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/fi/documents/all-authorised-presentations/trudexa-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (229.92 KB - PDF)

**First published:**

15/02/2008

**Last updated:**

15/02/2008

[View](/sv/documents/all-authorised-presentations/trudexa-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Trudexa Active substance adalimumab International non-proprietary name (INN) or common name adalimumab Therapeutic area (MeSH)

- Spondylitis, Ankylosing
- Arthritis, Rheumatoid
- Arthritis, Psoriatic
- Crohn Disease

Anatomical therapeutic chemical (ATC) code L04AA17

### Pharmacotherapeutic group

Immunosuppressants

### Therapeutic indication

**Rheumatoid arthritis**

- the treatment of moderate to severe, active rheumatoid arthritis in adult patients when the response to disease-modifying anti-rheumatic drugs including methotrexate has been inadequate.
- the treatment of severe, active and progressive rheumatoid arthritis in adults not previously treated with methotrexate.

Trudexa can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate.

Trudexa has been shown to reduce the rate of progression of joint damage as measured by X-ray and to improve physical function, when given in combination with methotrexate.

**Psoriatic arthritis** Trudexa is indicated for the treatment of active and progressive psoriatic arthritis in adults when the response to previous disease-modifying anti-rheumatic drug therapy has been inadequate.

**Ankylosing spondylitis** Trudexa is indicated for the treatment of adults with severe active ankylosing spondylitis who have had an inadequate response to conventional therapy.

**Crohn's disease** Trudexa is indicated for treatment of severe, active Crohn's disease, in patients who have not responded despite a full and adequate course of therapy with a corticosteroid and/or an immunosuppressant; or who are intolerant to or have medical contraindications for such therapies. For induction treatment, Trudexa should be given in combination with cortiocosteroids. Trudexa can be given as monotherapy in case of intolerance to corticosteroids or when continued treatment with corticosteroids is inappropriate (see section 4.2).

## Authorisation details

EMA product number EMEA/H/C/000482 Marketing authorisation holder

Abbott Laboratories Ltd.

Queenborough Kent ME11 5EL United Kingdom

Marketing authorisation issued 01/09/2003 Withdrawal of marketing authorisation 09/07/2007 Revision 8

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Trudexa : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (284.87 KB - PDF)

**First published:** 15/02/2008

**Last updated:** 15/02/2008

[View](/en/documents/procedural-steps-after/trudexa-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Trudexa-H-C-482-II-33 : EPAR - Scientific Discussion - Variation

Adopted

English (EN) (500.4 KB - PDF)

**First published:** 15/02/2008

**Last updated:** 15/02/2008

[View](/en/documents/scientific-discussion-variation/trudexa-h-c-482-ii-33-epar-scientific-discussion-variation_en.pdf)

Trudexa-H-C-482-II-06 : EPAR - Scientific Discussion - Variation

Adopted

English (EN) (432.91 KB - PDF)

**First published:** 15/02/2008

**Last updated:** 15/02/2008

[View](/en/documents/scientific-discussion-variation/trudexa-h-c-482-ii-06-epar-scientific-discussion-variation_en.pdf)

Trudexa-H-C-482-II-21 : EPAR - Scientific Discussion - Variation

Adopted

English (EN) (444.93 KB - PDF)

**First published:** 15/02/2008

**Last updated:** 15/02/2008

[View](/en/documents/scientific-discussion-variation/trudexa-h-c-482-ii-21-epar-scientific-discussion-variation_en.pdf)

Trudexa-H-C-482-II-22 : EPAR - Scientific Discussion - Variation

Adopted

English (EN) (454.94 KB - PDF)

**First published:** 15/02/2008

**Last updated:** 15/02/2008

[View](/en/documents/scientific-discussion-variation/trudexa-h-c-482-ii-22-epar-scientific-discussion-variation_en.pdf)

Trudexa-H-C-482-II-26 : EPAR - Scientific Discussion - Variation

Adopted

English (EN) (440.71 KB - PDF)

**First published:** 15/02/2008

**Last updated:** 15/02/2008

[View](/en/documents/scientific-discussion-variation/trudexa-h-c-482-ii-26-epar-scientific-discussion-variation_en.pdf)

## Initial marketing authorisation documents

Trudexa : EPAR - Procedural steps taken before authorisation

English (EN) (303.04 KB - PDF)

**First published:** 15/02/2008

**Last updated:** 15/02/2008

[View](/en/documents/procedural-steps/trudexa-epar-procedural-steps-taken-authorisation_en.pdf)

Trudexa : EPAR - Scientific Discussion

English (EN) (710.9 KB - PDF)

**First published:** 15/02/2008

**Last updated:** 15/02/2008

[View](/en/documents/scientific-discussion/trudexa-epar-scientific-discussion_en.pdf)

**This page was last updated on** 14/02/2008

## Share this page

[Back to top](#main-content)